BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28421553)

  • 21. Ultrasound-guided hydrodissection for assisting percutaneous microwave ablation of renal cell carcinomas adjacent to intestinal tracts: a preliminary clinical study.
    Cheng Z; Yu X; Han Z; Liu F; Yu J; Liang P
    Int J Hyperthermia; 2018 May; 34(3):315-320. PubMed ID: 28641464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous Microwave Ablation of Stage T1b Renal Cell Carcinoma: Short-Term Assessment of Technical Feasibility, Short-Term Oncologic Outcomes, and Safety.
    Guo J; Arellano RS
    J Endourol; 2020 Oct; 34(10):1021-1027. PubMed ID: 32498630
    [No Abstract]   [Full Text] [Related]  

  • 23. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
    Zhou W; Arellano RS
    J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
    McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
    J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous microwave ablation of renal masses in a UK cohort.
    John JB; Anderson M; Dutton T; Stott M; Crundwell M; Llewelyn R; Gemmell A; Bufacchi R; Spiers A; Campain N
    BJU Int; 2021 Apr; 127(4):486-494. PubMed ID: 32871034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Updated Systematic Review and Meta-Analysis on the Technical, Oncologic, and Safety Outcomes of Microwave Ablation in Patients with Renal Cell Carcinoma.
    Wu J; Sami S; Lajkosz K; Kishibe T; Ordon M
    J Endourol; 2023 Dec; 37(12):1314-1330. PubMed ID: 37819699
    [No Abstract]   [Full Text] [Related]  

  • 27. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
    Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
    BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of CT-guided microwave ablation for stage T1a renal cell carcinoma in patients with a solitary kidney.
    Meng H; Yang H; Jia H; Pan F; Dong X; Liu B; Li C
    Int J Hyperthermia; 2021; 38(1):691-695. PubMed ID: 33899668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the RENAL and mRENAL Scores and the Relative Importance of Their Components in the Prediction of Complications and Local Progression after Percutaneous Renal Cryoablation.
    Mouli SK; McDevitt JL; Su YK; Ragin AB; Gao Y; Nemcek AA; Lewandowski RJ; Salem R; Sato KT
    J Vasc Interv Radiol; 2017 Jun; 28(6):860-867. PubMed ID: 28291714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous Microwave Ablation Versus Robot-Assisted Partial Nephrectomy for Stage I Renal Cell Carcinoma: A Propensity-Matched Cohort Study Focusing Upon Long-Term Follow-Up of Oncologic Outcomes.
    Chlorogiannis DD; Kratiras Z; Efthymiou E; Moulavasilis N; Kelekis N; Chrisofos M; Stravodimos K; Filippiadis DK
    Cardiovasc Intervent Radiol; 2024 May; 47(5):573-582. PubMed ID: 38561521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous Microwave Ablation of Category T1a Renal Cell Carcinoma: Intermediate Results on Safety, Technical Feasibility, and Clinical Outcomes of 119 Tumors.
    Guo J; Arellano RS
    AJR Am J Roentgenol; 2021 Jan; 216(1):117-124. PubMed ID: 32603227
    [No Abstract]   [Full Text] [Related]  

  • 33. Percutaneous microwave ablation for local control of metastatic renal cell carcinoma.
    Maciolek KA; Abel EJ; Best SL; Emamekhoo H; Averill SL; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Wells SA
    Abdom Radiol (NY); 2018 Sep; 43(9):2446-2454. PubMed ID: 29464274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local tumor progression after ultrasound-guided percutaneous microwave ablation of stage T1a renal cell carcinoma: risk factors analysis of 171 tumors.
    Hao G; Hao Y; Cheng Z; Zhang X; Cao F; Yu X; Han Z; Liu F; Mu M; Dou J; Li X; Dupuy DE; Yu J; Liang P
    Int J Hyperthermia; 2018; 35(1):62-70. PubMed ID: 29807450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous microwave ablation on management of hereditary renal cell carcinoma in Von Hippel-Lindau disease.
    Chen J; Zheng L; Zhang W; Wang Z; Yu J; Liang P
    Int J Hyperthermia; 2024; 41(1):2308079. PubMed ID: 38346873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of lung tumours with high-energy microwave ablation: a single-centre experience.
    Ierardi AM; Coppola A; Lucchina N; Carrafiello G
    Med Oncol; 2017 Jan; 34(1):5. PubMed ID: 27900591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?
    Yu J; Wang H; Cheng ZG; Liu FY; Li QY; He GZ; Luo YC; Yu XL; Han ZY; Liang P
    Eur Radiol; 2022 Jan; 32(1):89-100. PubMed ID: 34195888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas.
    Shakeri S; Afshari Mirak S; Mohammadian Bajgiran A; Pantuck A; Sisk A; Ahuja P; Lu DS; Raman SS
    Abdom Radiol (NY); 2019 Jun; 44(6):2308-2315. PubMed ID: 30847565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
    Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours.
    Ma Y; Bedir S; Cadeddu JA; Gahan JC
    BJU Int; 2014 Jan; 113(1):51-5. PubMed ID: 24053553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.